GlassScriptPhysician profile
Samuel K Lee
NPI 1922023043
$8,713.87
in general payments reported to CMS, 2019-2025
32 companies · $1,771 in 2025
The $1,771 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $791 · 2020: $1,033 · 2021: $798 · 2022: $1,891 · 2023: $1,290 · 2024: $1,139 · 2025: $1,771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,822 · Education: $364 · Travel and Lodging: $14.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,821.99 |
| Education | $363.96 |
| Travel and Lodging | $14.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,652.38 | 2022-2025 | Interstim, Altaviva |
| Pfizer INC. | $1,642.85 | 2019-2025 | |
| Astellas Pharma US INC | $1,172.00 | 2019-2025 | Xtandi |
| Teleflex LLC | $754.78 | 2021-2025 | Urolift, Barrigel, Solesta |
| Sumitomo Pharma America, INC. | $580.24 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $439.91 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Coloplast Corp | $356.62 | 2020-2023 | Altis |
| Neotract INC. | $282.36 | 2019-2020 | |
| Abbvie INC. | $268.42 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $166.51 | 2025 | |
| Urovant Sciences INC | $165.92 | 2021-2022 | |
| Celltrion, INC. | $144.60 | 2020 | |
| Procept Biorobotics Corporation | $125.58 | 2024 | Aquabeam System |
| Olympus America INC. | $114.29 | 2020-2024 | Itind System |
| Dendreon Pharmaceuticals LLC | $91.88 | 2019-2025 | Provenge |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $87.69 | 2020-2022 | |
| Accord Healthcare, INC. | $84.34 | 2023-2025 | |
| Tolmar, INC. | $77.55 | 2023 | |
| Urogen Pharma, INC. | $75.86 | 2022-2025 | |
| Medtronic USA, INC. | $68.97 | 2020 | |
| Boston Scientific Corporation | $52.38 | 2023-2024 | Obtryx System - Curved, Rezum Generator |
| C. R. Bard, INC. & Subsidiaries | $42.49 | 2023 | Bard Urinary Drainage Bag |
| Progenics Pharmaceuticals, INC. | $41.31 | 2025 | |
| Roche Diagnostics Corporation | $40.38 | 2019 | |
| Alnylam Pharmaceuticals INC. | $35.12 | 2025 | Givlaari |
| Myovant Sciences INC. | $23.93 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $23.73 | 2024 | |
| Avadel Specialty Pharmaceuticals, LLC | $22.66 | 2019 | |
| Allergan, INC. | $22.57 | 2019 | |
| Endo USA, INC. | $21.21 | 2025 | Xiaflex |
| Integra Lifesciences Corporation | $18.37 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Neurocrine Biosciences, INC. | $16.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.